Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000913

Drug Information
NameMasoprocol
Synonyms741285-10-9; meso-NDGA; NCGC00094201-01; NDGA; C18H22O4; EU-0100877; 4-[(2S,3R)-4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol; AC1Q7ACC; AC1L2G35; 27686-84-6; DB00179; (R*,S*)-4,4'-(2,3-Dimethylbutane-1,4-diyl)bispyrocatechol; 334707-72-1; 1,2-Benzenediol, 4,4'-(2,3-dimethyl-1,4-butanediyl)bis-, (R*,S*)-; meso-4,4'-(2,3-Dimethyltetramethylene)dipyrocatechol; 1,2-Benzenediol, 4,4'-((2R,3S)-2,3-dimethyl-1,4-butanediyl)bis-, rel-; EINECS 248-606-6; D04862; CHX-100; 1,2-Benzenediol, 4,4'-(2,3-dimethyl-1,4-butanediyl)bis-, (R*,S*)-; Masoprocol (USAN/INN); NCGC00094201-04; ZINC00012342; CID71398; Nordihydroguaiaretic acid (meso-form); ZINC12359927; Actinex (TN); Lopac0_000877; Lopac-N-5023; C10719; 500-38-9; BIDD:ER0127; Masoprocolum [INN-Latin]; NCGC00015741-03; NCGC00094201-02; TNP00263; Actinex; UNII-7BO8G1BYQU; CHX 100; NCGC00015741-02; Masoprocolum; meso-Nordihydroguaiaretic acid; meso-4,4'-(2,3-Dimethyltetramethylene)dipyrocatechol; Nordihydroguaiaretic acid from Larrea divaricata (creosote bush); LS-174190; Masoprocol; CHEMBL313972; Masoprocol [USAN:INN]; N 5023; NCGC00015741-01
IndicationProstate cancer
[ICD9: 185   ICD10: C61]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C18H22O4/c1-11(7-13-3-5-15(19)17(21)9-13)12(2)8-14-4-6-16(20)1
8(22)10-14/h3-6,9-12,19-22H,7-8H2,1-2H3/t11-,12+
InChIKeyHCZKYJDFEPMADG-TXEJJXNPSA-N
Canonical SMILESCC(CC1=CC(=C(C=C1)O)O)C(C)CC2=CC(=C(C=C2)O)O    
Isomeric SMILESC[C@H](CC1=CC(=C(C=C1)O)O)[C@@H](C)CC2=CC(=C(C=C2)O)O
Therapeutic ClassAntineoplastic Agents
CAS NumberCAS 500-38-9
FormulaC18H22O4
PubChem Compound IDCID 71398.
PubChem Substance IDSID 12902.
SuperDrug ATC IDL01XX10
SuperDrug CAS ID027686846;
TargetArachidonate 5-lipoxygenaseInhibitor[2]
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2Masoprocol decreases rat lipolytic activity by decreasing the phosphorylation of HSL. Am J Physiol Endocrinol Metab. 2000 Sep;279(3):E593-600. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543